๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non-Hodgkin's lymphoma

โœ Scribed by Lawrence J. Ettinger; David S. Chervinsky; Arnold I. Freeman; Patrick J. Creaven

Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
605 KB
Volume
50
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Tumor lysis syndrome occurring after the
Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: High-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia
โœ Yang, Honghao; Rosove, Michael H.; Figlin, Robert A. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 27 KB ๐Ÿ‘ 2 views

Rituximab, an anti-CD20 antibody, has been recently approved for the treatment of lowgrade or follicular non-Hodgkin's lymphoma (NHL). Because of its relatively benign side effect profile, it has been considered a nontoxic alternative to chemotherapy. Recently, however, tumor lysis syndrome (TLS) re

Subsequent development of acute non-lymp
Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin's disease
โœ J. W. van der Velden; W. L. J. van Putten; V. F. Guinee; R. Pfeiffer; F. E. van ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 481 KB ๐Ÿ‘ 1 views

A nested case control study was carried out to investigate the association between treatment of patients with Hodgkin's disease (HD) and the risk of developing acute non-lymphocytic leukemia (ANLL). Seven Cancer Centers of the International Cancer Patient Data Exchange System of the UlCC participate